A study for a 90 year old woman who takes Namenda - from FDA reports

1,788 females aged 90 (±5) who take the same drug are studied. This is a personalized study for a 90 year old female patient who has Dementia Due To Metabolic Causes. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 14, 2019

1,788 females aged 90 (±5) who take Namenda are studied.

Number of reports submitted per year:

Namenda for a 90-year old woman.

Information of the patient in this study:

  • Age: 90
  • Gender: female
  • Conditions: Dementia Due To Metabolic Causes
  • Drugs taken:
    • Namenda (memantine hydrochloride)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Confusional state
  2. Dizziness
  3. Urinary tract infection
  4. Constipation
  5. Hallucinations (sensations that appear real but are created by your mind)
  6. High blood pressure
  7. Diarrhea
  8. Fever
  9. Nausea and vomiting
  10. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
1 - 6 months:
  1. Dizziness
  2. Drowsiness
  3. Loss of consciousness
  4. Confusional state
  5. Aggression
  6. Agitation (state of anxiety or nervous excitement)
  7. Fall
  8. Urinary tract infection
  9. Hypokalemia (low potassium)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
6 - 12 months:
  1. Agitation (state of anxiety or nervous excitement)
  2. Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles)
  3. Drowsiness
  4. Fall
  5. Hepatitis (inflammation of the liver)
  6. Cardiac failure
  7. Hepatic cyst
  8. Dizziness
  9. Low tissue oxygen
  10. Skin haemorrhage (bleeding into skin)
1 - 2 years:
  1. Pancreatitis (inflammation of pancreas)
  2. Fall
  3. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Wound infection
  6. Pvt
  7. Haemoglobin decreased
  8. Gallstones (stone formation by bile component)
  9. Pneumonia
  10. Intestinal obstruction
2 - 5 years:
  1. Urinary tract infection
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Fever
  4. Agitation (state of anxiety or nervous excitement)
  5. Fall
  6. Interstitial lung disease
  7. General physical health deterioration (weak health status)
  8. Cerebral haematoma (collection of blood in brain)
  9. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  10. Muscle rigidity (muscle stiffness)
5 - 10 years:
  1. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  2. Fall
  3. Nervousness
  4. Hypokinesia (decreased bodily movement)
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  6. Hepatitis toxic
  7. Weakness
  8. Hepatitis (inflammation of the liver)
  9. Spinal fracture (fracture in one of vertebrae)
  10. Pancreatitis acute (sudden inflammation of pancreas)
10+ years:
  1. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  2. Dizziness
not specified:
  1. Fall
  2. Confusional state
  3. Drowsiness
  4. Fatigue (feeling of tiredness)
  5. Urinary tract infection
  6. Dizziness
  7. Weakness
  8. Pneumonia
  9. Death
  10. Hypotension (abnormally low blood pressure)

Top conditions involved for these people *:

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 722 people, 40.38%
  2. High Blood Pressure : 113 people, 6.32%
  3. Depression : 91 people, 5.09%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 69 people, 3.86%
  5. Osteoporosis (bones weak and more likely to break): 54 people, 3.02%
  6. High Blood Cholesterol : 39 people, 2.18%
  7. Pain : 37 people, 2.07%
  8. Constipation : 31 people, 1.73%
  9. Stress And Anxiety : 28 people, 1.57%
  10. Agitation (state of anxiety or nervous excitement): 27 people, 1.51%

Top co-used drugs for these people *:

  1. Aricept (467 people, 26.12%)
  2. Aspirin (199 people, 11.13%)
  3. Synthroid (136 people, 7.61%)
  4. Lasix (123 people, 6.88%)
  5. Exelon (118 people, 6.60%)
  6. Plavix (116 people, 6.49%)
  7. Norvasc (107 people, 5.98%)
  8. Seroquel (86 people, 4.81%)
  9. Furosemide (77 people, 4.31%)
  10. Coumadin (71 people, 3.97%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!